Harrow Health Inc. (HROW) experienced a significant after-hours plunge of 10.43% following the release of its fourth-quarter and full-year 2025 financial results.
The sharp decline came as the company reported quarterly earnings that fell significantly short of analyst expectations. Harrow posted Q4 earnings per share of $0.17, which not only represented a decrease from $0.24 in the same period a year earlier but also missed the FactSet consensus estimate of $0.37 by a wide margin.
Adding to investor concerns, the company issued 2026 revenue guidance of $350 million to $365 million, which falls substantially below analyst expectations of $391.4 million. This combination of an earnings miss and weaker-than-expected forward outlook prompted the after-hours selloff.